<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03587948</url>
  </required_header>
  <id_info>
    <org_study_id>2018004</org_study_id>
    <nct_id>NCT03587948</nct_id>
  </id_info>
  <brief_title>Shanghai Children and Adolescent Diabetes Eye Study</brief_title>
  <acronym>SCADE</acronym>
  <official_title>Shanghai Children and Adolescent Diabetes Eye Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Eye Disease Prevention and Treatment Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Eye Disease Prevention and Treatment Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the prevalence of eye disease between children and adolescents with diabetes
      mellitus and healthy people, and to analyze the related factors of eye diseases in diabetic
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cohort study. From January 2018 to 2028, 300 cases of diabetic children in Children's
      Hospital of Fudan University in Shanghai will be selected as case group, and 300 healthy
      children without diabetes will be selected as the control group.

      The purpose of the study is to guide and regulate eye health screening of children and
      adolescents with diabetes in Children's Hospital of Fudan University in Shanghai, build up
      the ranks with the general practitioner as the backbone combined, and provide comprehensive,
      continuous, and dynamic information service to diabetic eye disease health management. We
      expect to reduce the prevalence rate of diabetic eye disease, blindness and visual impairment
      of DR, and improve diabetics consciousness of eye health maintenance, thus upgrading the
      level of eye disease prevention and treatment in Shanghai.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2028</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2028</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diabetic eye diseases</measure>
    <time_frame>January 1, 2028</time_frame>
    <description>Prevalence of eye diseases due to diabetes.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Eye Diseases</condition>
  <arm_group>
    <arm_group_label>Case group</arm_group_label>
    <description>Children and adolescents with diabetes mellitus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Children and adolescents without diabetes mellitus</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Diabetes mellitus</intervention_name>
    <description>Children and adolescents who is diagnosed with diabetes will be involved in case-group, and others will be involved in control-group.</description>
    <arm_group_label>Case group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        From January 2018 to 2028, children who are diagnosed with diabetes at the Children's
        Hospital of Fudan University in Shanghai, will be recruited as cases of diabetes. We will
        also recruit children without diabetes, who will be matched for age and gender, from this
        hospital as controls.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  (1) provision of a written informed consent by a guardian;

          -  (2) age over 5 years and less than 18 years;

          -  (3) diagnosis of type 1 or type 2 diabetes based on the WHO diagnostic criteria for
             cases.

        Exclusion Criteria:

          -  (1) eyelid diseases - eyelid entropion, eyelid ectropion, eyelid, ptosis, and
             palpebral dyskinesia;

          -  (2) conjunctival diseases - pterygium and conjunctivitis;

          -  (3) history of ocular surface chemical injury or use of eye drops with moisturizing
             artificial tears;

          -  (4) history of eye surgery within 6 months or history of retinal laser
             photocoagulation;

          -  (5) systemic diseases - Sjogren syndrome, Parkinson's disease, rheumatoid arthritis,
             Grave 's disease, systemic lupus erythematosus, and others.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haidong Zou, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai Eye Disease Prevention and Treatment Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Haidong Zou, post-doctor</last_name>
    <phone>13311986528</phone>
    <email>zouhaidong@263.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Eye Disease Prevention &amp; Treatment Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haidong Zou, Ph.D</last_name>
      <phone>8613311986528</phone>
      <email>zouhaidong@263.net</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 3, 2018</study_first_submitted>
  <study_first_submitted_qc>July 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2018</study_first_posted>
  <last_update_submitted>July 3, 2018</last_update_submitted>
  <last_update_submitted_qc>July 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

